Conveners
S01 3D in vitro tissue-engineered cancer/disease models – Session I
- Anna-Dimitra Kataki
- Silvia Farè
-
Varghese, Shyni (Duke University)6/28/22, 11:00 AMinvited lecture
"Cancer is a complex disease system in which the extracellular microenvironment provides robust physicochemical cues to promote disease progression and resistance to therapy. Immunotherapies have been considered as an efficient therapeutic strategy to treat cancer and are being studied for their potential to improve prognosis and long-term survival of patients. While early clinical data shows...
Go to contribution page -
Cidonio, Gianluca (Italian Institute of Technology )6/28/22, 11:20 AMpodium presentation
Bone is a frequent homing site for breast cancer metastasis. Unfortunately, the majority of patients diagnosed with primary breast cancer is often affected by bone metastasis from where cancer can reach other vital organs such as the lungs. Thus, it is vital that the process of metastatic attraction and homing is modeled in vitro, harnessing tissue engineering technology, generating viable...
Go to contribution page -
Van Tienderen, Gilles (Department of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam )6/28/22, 11:30 AMpodium presentation
Background and Aims: Cholangiocarcinoma (CCA) is an aggressive, heterogeneous cancer with low survival rates. Patient-derived cholangiocarcinoma organoids (CCAOs) hold potential for understanding disease progression and developing novel treatment options, based on their ability to mimic the original tumor. However, a hallmark of cancer is the disturbance of morphological cues resulting in...
Go to contribution page -
Kast, Verena (Leibniz Institute of Polymer Research Dresden e.V., Max Bergmann Center of Biomaterials)6/28/22, 11:40 AMpodium presentation
Introduction: Pancreatic cancer is a devastating malignancy, and treatment options are very limited [1]. Progression of the disease and resistance to therapy are mediated by the tumour microenvironment (TME), which is composed of excessive amounts of extracellular matrix proteins, as well as stromal and immune cells, acting as a physical barrier for drug delivery [1-3]. Cell-secreted factors,...
Go to contribution page -
Santin, Matteo (Centre for Regenerative Medicine and Devices / University of Brighton )6/28/22, 11:50 AMpodium presentation
Nanomedicine, where therapeutic or diagnostic agents are coupled with nanoparticles (NP), offers opportunities for more efficacious treatments and accurate diagnosis of severe clinical conditions. Polymeric, lipidic, metallic or ceramic NP have been considered as carriers of these agents, but their translation into clinics requires a thorough assessment of their biocompatibility and...
Go to contribution page -
Kataki, Anna-Dimitra6/28/22, 12:00 PMpodium presentation
INTRODUCTION:Termed as the ‘silent killer’,epithelial ovarian cancer (EOC) earns its nickname due to its high mortality rate, with 5-year survival rates of 46%,46.5% and 38% in UK, USA & Europe respectively.This has been attributed to some extent to the EOC’s high recurrence rate and resistance to currently available platinum based chemotherapeutic treatment methods. Hence,society,...
Go to contribution page -
Neto, Mafalda D. (INL - International Iberian Nanotechnology Laboratory )6/28/22, 12:10 PMpodium presentation
Introduction: The assessment of bioaccessibility and bioavailability of orally-ingested compounds is key to determine their efficacy and safety. However, there is a lack of toxicological studies that combine simulated gastrointestinal (GI) digestion with subsequent intestinal absorption. Many studies expose cells directly to pristine bioactive substances, failing to consider the series of...
Go to contribution page -
Curvello, Rodrigo (Monash University )6/28/22, 12:20 PMpodium presentation
Introduction: Bioengineered 3D cancer models allow the deconstruction of the tumour microenvironment in vitro to recreate the dynamic interactions between its extracellular and intracellular components. These bioengineered systems strongly rely on Matrigel, an undefined animal-derived matrix, to support the growth of cancer spheroids and organoids [1]. Despite its wide usage, Matrigel has poor...
Go to contribution page -
Amorim, Sara (3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine )podium presentation
Introduction. Glioblastoma multiforme (GBM) is the most common and aggressive primary brain cancer, with a five-year relative survival rate (after diagnosis) of only 36%.[1] GBM is characterized for its fast proliferation rate and angiogenic character, making it the leading cause of cancer-related deaths in young adults.[2] During the onset and evolution of GBM, the composition of its...
Go to contribution page